J Allergy Clin Immunol Pract. 2013 Mar;1(2):152-6. doi: 10.1016/j.jaip.2012.10.008.
Prediction of subsequent school-age asthma during the preschool years has proven challenging.
To confirm in a post hoc analysis the predictive ability of the modified Asthma Predictive Index (mAPI) ina high-risk cohort and a theoretical unselected population. We also tested a potential mAPI modification with a 2-wheezing episode requirement (m2API) in the same populations.
Subjects (n [ 289) with a family history of allergy and/or asthma were used to predict asthma at age 6, 8, and 11 years with the use of characteristics collected during the first 3 years of life. The mAPI and the m2API were tested for predictive value.
For the mAPI and m2API, school-age asthma prediction improved from 1 to 3 years of age. The mAPI had high predictive value after a positive test (positive likelihood ratio ranging from 4.9 to 55) for asthma development at years 6,8, and 11. Lowering the number of wheezing episodes to 2(m2API) lowered the predictive value after a positive test(positive likelihood ratio ranging from 1.91 to 13.1) without meaningfully improving the predictive value of a negative test.Posttest probabilities for a positive mAPI reached 72% and 90%in unselected and high-risk populations, respectively.
In a high-risk cohort, a positive mAPI greatly increased future asthma probability (eg, 30% pretest probability to 90% posttest probability) and is a preferred predictive test to them 2API. With its more favorable positive posttest probability,the mAPI can aid clinical decision making in assessing future asthma risk for preschool-age children.
在学龄前预测后续学龄期哮喘具有挑战性。
在后分析中确认改良哮喘预测指数(mAPI)在高危队列和理论上未选择人群中的预测能力。我们还在相同人群中测试了具有 2 次喘息发作要求的潜在 mAPI 改良(m2API)。
使用收集的生命前 3 年的特征,对具有过敏和/或哮喘家族史的受试者(n [289)进行预测,以预测 6、8 和 11 岁时的哮喘。测试 mAPI 和 m2API 的预测值。
对于 mAPI 和 m2API,从 1 岁到 3 岁,学龄期哮喘的预测有所改善。阳性测试后,mAPI 具有较高的预测值(阳性似然比范围为 4.9 至 55),用于预测 6、8 和 11 岁的哮喘发展。将喘息发作次数降低至 2 次(m2API)会降低阳性测试后的预测值(阳性似然比范围为 1.91 至 13.1),而不会显著改善阴性测试的预测值。阳性 mAPI 的后验概率在未选择人群和高危人群中分别达到 72%和 90%。
在高危队列中,阳性 mAPI 大大增加了未来哮喘的可能性(例如,30%的术前概率增加到 90%的术后概率),并且是一种首选的预测测试,而不是 m2API。阳性后验概率更有利,mAPI 可以帮助临床决策,评估学龄前儿童未来的哮喘风险。